Stable Coronary Artery Disease
Showing 1 - 25 of >10,000
Stable Coronary Artery Disease Trial in Foshan
Recruiting
- Stable Coronary Artery Disease
-
Foshan, Guangdong, ChinaNanhai Hospital, Guangdong Provincial People's Hospital
Nov 7, 2023
Treatment Decision, Coronary Artery Disease Trial in Beijing, Zhengzhou, Changchun (Invasive coronary angiography, routine
Recruiting
- Treatment Decision, Coronary Artery Disease
- Invasive coronary angiography
- routine medical treatment
-
Beijing, Beijing, China
- +3 more
Oct 31, 2023
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
Recruiting
- Chronic Total Occlusion
- Coronary Artery Disease
- Coronary angiography
-
Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Nov 13, 2023
Coronary Artery Disease, Prediabetic State Trial in Seoul (Dapagliflozin 10mg, Lifestyle modification)
Terminated
- Coronary Artery Disease
- Prediabetic State
- Dapagliflozin 10mg
- Lifestyle modification
-
Seoul, Korea, Republic ofAsan Medical Center
Sep 21, 2022
Tertiary A-level Hospital Remote Intervention on MACCE,
Recruiting
- Stable Chronic Angina
- +2 more
- Intervention
- Control
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Science; National Cen
Oct 20, 2022
Coronary Artery Disease, Stable Angina, Myocardial Ischaemia Trial in London (MR perfusion guidance, FFR guidance)
Completed
- Coronary Artery Disease
- +2 more
- MR perfusion guidance
- FFR guidance
-
London, United KingdomKing's College
Jun 21, 2022
Coronary Artery Disease Trial in Kingston upon Hull (Cardiogoniometry (CGM), Fractional Flow Reserve (FFR))
Completed
- Coronary Artery Disease
- Cardiogoniometry (CGM)
- Fractional Flow Reserve (FFR)
-
Kingston upon Hull, East Yorkshire, United KingdomCastle Hill Hospital
Aug 16, 2022
Cardiovascular Disease, Atherosclerosis, Coronary Artery Disease Trial in Houston (Comprehensive therapy program for risk factor
Active, not recruiting
- Cardiovascular Disease
- +3 more
- Comprehensive therapy program for risk factor modification
-
Houston, TexasWeatherhead PET Center, Memorial Hermann Hospital TMC
May 20, 2022
Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)
Not yet recruiting
- Coronary Artery Disease
- +2 more
- heated tobacco - lifestyle intervention
-
Warsaw, PolandNational Institute of Cardiology
Dec 27, 2022
Coronary Artery Disease, Healthy Participants Trial in Edinburgh (Ticagrelor, BMS-986141, Aspirin)
Recruiting
- Coronary Artery Disease
- Healthy Participants
- Ticagrelor
- +2 more
-
Edinburgh, United KingdomLocal Institution - 0001
May 3, 2022
Stable Coronary Artery Disease (CAD), Unstable Angina (Troponin Negative) Trial in Frankfurt am Main, Rotenburg an der Fulda
Completed
- Stable Coronary Artery Disease (CAD)
- Unstable Angina (Troponin Negative)
-
Frankfurt am Main, Hessen, Germany
- +1 more
Feb 24, 2023
Platelet Reactivity Trial in Harbin (Ticagrelor 90mg, Clopidogrel 75mg)
Completed
- Platelet Reactivity
- Ticagrelor 90mg
- Clopidogrel 75mg
-
Harbin, Heilongjiang, ChinaThrombelastogram
Dec 20, 2021
Prior to Revascularization
Recruiting
- Coronary Artery Disease
- Angina, Stable
- Percutaneous coronary intervention
-
Basildon, Essex, United Kingdom
- +1 more
Sep 2, 2022
Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Impact of current PCI techniques/ devices in
Recruiting
- Coronary Disease
- +9 more
- Impact of current PCI techniques/ devices in complex coronary artery lesions
-
Lucerne, SwitzerlandLucerne Heart Centre
Oct 4, 2023
Stable Angina, Coronary Artery Disease Trial in Kaunas (coronary pressure/temperature sensor-tipped guidewire,
Recruiting
- Stable Angina
- Coronary Artery Disease
- coronary pressure/temperature sensor-tipped guidewire
- Angiography-derived index of microcirculatory resistance (IMRangio)
-
Kaunas, LithuaniaLithuanian University of Health Sciences
Mar 15, 2023
Angina, Stable Trial in Denmark, Sweden (CADScor®System)
Recruiting
- Angina, Stable
- CADScor®System
-
Copenhagen S, Denmark
- +5 more
Mar 1, 2022
Angiotensin Converting Enzyme rs Gene Polymorphism and
Recruiting
- Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
- DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
-
Sohag, EgyptSohag university Hospital
Sep 20, 2023
Stable Coronary Artery Disease Trial in Pavia (Atorvastatin)
Terminated
- Stable Coronary Artery Disease
-
Pavia, ItalyFondazione Irccs Policlinico San Matteo
Aug 30, 2021
Chronic Coronary Syndrome, Myocardial Ischemia, Stable Angina Trial in Herning (Optimization of guideline-directed medical
Recruiting
- Chronic Coronary Syndrome
- +3 more
- Optimization of guideline-directed medical therapy
- +3 more
-
Herning, Central Denmark Region, DenmarkGødstrup Hospital
May 23, 2023
Stable Ischemic Heart Disease Trial in Moscow (Patients with documented IHD)
Active, not recruiting
- Stable Ischemic Heart Disease
- Patients with documented IHD
-
Moscow, Russian FederationNational Research Center for Preventive Medicine
Aug 11, 2021
Angina, Stable, Coronary Artery Disease Trial in Shanghai (CT-FFR, QFR)
Not yet recruiting
- Angina, Stable
- Coronary Artery Disease
- CT-FFR
- QFR
-
Shanghai, Shagnhai, ChinaZhongshan Hospital, Fudan University
May 12, 2023
Platelet Reactivity Trial in Harbin (low-dose ticagrelor, Clopidogrel)
Completed
- Platelet Reactivity
- low-dose ticagrelor
- Clopidogrel
-
Harbin, California, ChinaVerifyNow
Dec 20, 2021
Coronary Artery Disease Trial in Germany (Vericiguat (BAY1021189), Placebo, Isosorbide mononitrate (ISMN))
Completed
- Coronary Artery Disease
- Vericiguat (BAY1021189)
- +2 more
-
Bad Krozingen, Baden-Württemberg, Germany
- +5 more
Dec 9, 2021
Coronary Artery Disease Trial in Aarhus (atorvastatin, rosuvastatin, ezetimibe)
Completed
- Coronary Artery Disease
- High intensity lipid lowering
-
Aarhus, Denamrk, DenmarkAarhus University Hospital
Nov 9, 2022
Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of
Recruiting
- Stable Ischemic Heart Disease
- +2 more
- Medical Assessment
- Quality of Life Assessment
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jan 30, 2023